La bourse est fermée

IDEXX Laboratories, Inc. (IDXX)

NasdaqGS - NasdaqGS Cours en temps réel. Devise en USD
Ajouter à la liste dynamique
500,08+6,53 (+1,32 %)
À la clôture : 04:00PM EDT
502,00 +1,92 (+0,38 %)
Échanges après Bourse : 07:54PM EDT

IDEXX Laboratories, Inc.

One IDEXX Drive
Westbrook, ME 04092
United States
207 556 0300
https://www.idexx.com

Secteur(s)Healthcare
Secteur d’activitéDiagnostics & Research
Employés à temps plein10 780

Dirigeants clés

NomTitrePayerExercéAnnée de naissance
Mr. Jonathan J. MazelskyPres, CEO & Director3,07M12,86M1961
Mr. Brian P. McKeonExec. VP & CFO1,43M26,11M1962
Mr. James F. PolewaczykExec. VP & Chief Commercial Officer1,19M5,61M1964
Mr. Michael J. LaneExec. VP and GM of Reference Laboratories & Information Technology1,19M4,05M1968
Dr. Nimrata Khatra Hunt P.E., Ph.D.Exec. VP of Strategy, Sector Devel. & Global Operations1,18M946,84k1969
Mr. John HartSr. VP of Global OperationsS.O.S.O.S.O.
Mr. Jeffery D. ChadbourneSr. Director of Accounting & Financial ReportingS.O.S.O.1976
Dr. Martin Smith Ph.D.Exec. VP & CTOS.O.S.O.1968
Mr. Ken GradySr. VP & Chief Information OfficerS.O.S.O.S.O.
Ms. Sharon E. UnderbergExec. VP, Gen. Counsel, & Corp. Sec.S.O.S.O.1961
Les montants ont été établis en date du 31 décembre 2021 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; OPTI SARS-CoV-2 RT-PCR test kit for human COVID-19 testing; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Gouvernance d’entreprise

L’ISS Governance QualityScore de IDEXX Laboratories, Inc. en date du 30 mars 2023 est 5. Les scores principaux sont Audit : 7; Société : 1; Droits des actionnaires : 9; Compensation : 3.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.